Dianthus Therapeutics | Spese Operative



Operating Expenses Cambiamento Data
Adcock Ingram Holdings ZAR 4.42B 268.95M 2024-06
Alaunos Therapeutics USD 1.15M 20K 2024-09
Avita Medical AUD 28.36M 2.44M 2024-12
Celltrion KRW 674.25B 128.01B 2024-09
Cspc Pharmaceutical CNY 5.42B 102.74M 2024-09
Dianthus Therapeutics USD 32.07M 8M 2024-09
Ecofibre AUD 12.31M 44.07M 2024-06
IQVIA Holdings USD 3.33B 14M 2024-12
Kangmei Pharma CNY 1.46B 193.63M 2024-09
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Laboratorios Farma EUR 141M 9.11M 2024-06
Malin Corporation EUR 700K 1.6M 2024-06
Medical Developments International AUD 10.35M 17.73M 2024-06
Moderna USD 2.21B 280M 2024-12
Neuren Pharmaceuticals AUD 17.41M 2.86M 2024-12
Organigram Holdings CAD 54.04M 9.62M 2024-12
Organon & Co USD 1.46B 88M 2024-12
Pharma Mar EUR 43.47M 3.3M 2024-12
Qiagen NV USD 377.04M 4.6M 2024-12
Revvity USD 610.62M 24.72M 2024-12
Sartorius EUR 725.4M 29M 2024-09
Sino Biopharmaceutical CNY 6.2B 2.04B 2024-06
Tectonic Therapeutic USD 19.64M 8.22M 2024-09
Tilray USD 253.17M 16.55M 2024-11
Viatris USD 3.55B 84.2M 2024-12
Xeris Pharmaceuticals USD 67.16M 10.91M 2024-09
Zz Pientze Pharmaceu 1.67B 86.7M 2024-09



Dianthus Therapeutics Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.